Delivery Order SPE2DB22D2218-SPE2DB25FR2VM

Award Date 6/24/25
Potential Completion Date 6/25/25
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,086.44, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Adacel TDAP Vial 0.5ML, a vaccine product, with a completion date of May 5, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,058.81 firm fixed-price delivery order is for the supply of ADACEL TDAP VIAL 0.5ML, a vaccine product. The award is not designated as a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,317.45 Firm Fixed Price Delivery Order is for the supply of ADACEL TDAP VIAL 0.5ML, a vaccine product. The contract has an ultimate completion date of December 13, 2024. Amerisourcebergen is the prime contractor for this award, which is not designated as a set-aside contract. The company holds a significant...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,035.23 firm-fixed-price contract is for the supply of ADACEL TDAP VIAL 0.5ML, a vaccine product, with a period of performance through February 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a primary vehicle for...
This federal contract award is for the delivery of ADACEL TDAP VIAL 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The $2,906.34 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on May 31, 2024, with a completion date of June 3, 2024. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of ADACEL TDAP VIAL 0.5ML, a vaccine product, with a firm fixed price of $1,248.06 and a period of performance through June 18, 2025. The contract is not set aside and was competitively awarded. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,021.80 firm fixed price delivery order is for the supply of 4,564,113,350 units of the ADACEL TDAP vaccine in 0.5 mL vials. The award has an ultimate completion date of April 1, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,826.30 firm fixed-price delivery order is for ADACEL TDAP SYRINGE 0.5ML medical supplies, with a performance period extending through June 13, 2025. The contract is not set aside and was competitively awarded. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $17,692.40 firm-fixed-price contract is for the delivery of ADACEL TDAP SYRINGE 0.5ML, a vaccine product. The award has a period of performance through September 5, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for the company to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,272.40 firm-fixed-price delivery order is for the provision of 4566378192 Adacel TDAP syringes. The contract has an ultimate completion date of November 12, 2024 and was awarded on November 8, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
  • SPE2DB22D2218
    Indefinite Delivery Contract
  • SPE2DB22D2218-SPE2DB25FR2VM
    Delivery Order

This federal contract award is a delivery order with a firm fixed price of $1,086.44 awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Adacel TDAP Vial 0.5ML, a vaccine product, with an ultimate completion date of June 25, 2025. The award was made by the Defense Logistics Agency (DLA), a defense agency, and is not designated as a set-aside contract.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order is likely a task or call order issued under that broader IDC framework, enabling the company to supply a range of pharmaceutical products and medical supplies to support military and federal healthcare programs.

Generated 9/28/25, 2:05 AM